Search Results - "KUIKE, Matthew H"

Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors by KUIKE, Matthew H, STUART, Keith, ENZINGER, Peter C, RYAN, David P, CLARK, Jeffrey W, MUZIKANSKY, Alona, VINCITORE, Michele, MICHELINI, Ann, FUCHS, Charles S

“…Standard, intravenous chemotherapy regimens for neuroendocrine tumors have been associated with limited response rates and significant toxicity. We evaluated…”
Get full text

Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer by KUIKE, Matthew H, BLASZKOWSKY, Lawrence S, FUCHS, Charles S, RYAN, David P, CLARK, Jeffrey W, MEYERHARDT, Jeffrey A, ZHU, Andrew X, ENZINGER, Peter C, KWAK, Eunice L, MUZIKANSKY, Alona, LAWRENCE, Colleen

“…The addition of either capecitabine or erlotinib to gemcitabine in the first-line treatment of advanced pancreatic cancer is associated with modest…”
Get full text

Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer by MEYERHARDT, Jeffrey A, ZHU, Andrew X, FUCHS, Charles S, ENZINGER, Peter C, RYAN, David P, CLARK, Jeffrey W, KUIKE, Matthew H, EARLE, Craig C, VINCITORE, Michele, MICHELINI, Ann, SHEEHAN, Susan

“…To investigate the combination of erlotinib, capecitabine, and oxaliplatin in patients who were previously treated for metastatic colorectal cancer. Patients…”
Get full text

Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer by Meyerhardt, Jeffrey A., Zhu, Andrew X., Stuart, Keith, Ryan, David P., Blaszkowsky, Lawrence, Lehman, Nicole, Earle, Craig C., Kulke, Matthew H., Bhargava, Pankaj, Fuchs, Charles S.

“…There is no standard chemotherapy option for patients with biliary tract cancers. These patients present fairly ill and can have a rapid progression of…”
Get full text